Home / Market / Company Snapshot

Ind-Swift Laboratories Ltd

HSL Code: INDSWF | BSE Code: 532305 | NSE Symbol: INDSWFTLAB | ISIN: INE915B01019

Fetching Data...

research reports

No Record Found.

news

Jun3	Results - Announcements on Monday 11:19 Ind-Swift Laboratories reports net loss of Rs 24.24 crore in the March 2013 quarter 630648
Mar13	Corporate News on Wednesday 16:07 Atul Saxena ceases as nominee director of Ind-Swift Laboratories 615243
Feb14	Results - Announcements on Thursday 12:01 Ind-Swift Laboratories reports net loss of Rs 12.03 crore in the December 2012 quarter 608684
Jan4	Corporate News on Friday 10:46 Ind-Swift Laboratories gets nod for debt restructuring 599615
Nov8	Results - Announcements on Thursday 12:26 Ind-Swift Laboratories reports net loss of Rs 39.38 crore in the September 2012 quarter 590130

Key Ratios

Market Cap (Rs. in Cr.)	148.64
Book Value	121.41
EPS (TTM)	-22.20
Price/Book	0.32
Face value	10.00
P/E	NM
Div(%)	10.00
Div Yield(%)	0.00

Fetching Data...

Rs. Cr.	Mar 13	Dec 12	Sep 12
Total Income	225.62	234.94	335.78
Total Expenses	202.43	209.33	336.00
EBITDA	24.15	25.61	-0.22
EBIT	8.09	11.56	-12.54
PBT	-24.24	-12.03	-39.38
PAT	-24.24	-12.03	-39.38
Net Profit	-24.24	-12.03	-39.38

Values Based on Standalone Data

Peer Group

More Compare

Sun Pharma.Inds. (NSE) 961.25(-1.10%)
Dr Reddy`s Labs (NSE) 2,099.70(-1.47%)
Cipla (NSE) 379.50(-0.04%)
Cadila Health. (NSE) 792.95(1.90%)
Glenmark Pharma. (NSE) 571.45(-0.43%)

Shareholding Pattern

	Promoters	50.58%
	Mutual Funds / UTI	0.00%
	FI / Banks	0.06%
	Insurance	0.00%
	Government	0.00%
	FII	4.19%
	Others	45.16%

Announcements & Events

Announcements
events

Mar14	Atul Saxena Ceases As Nominee Director Of Ind-Swift Laboratories
Jan4	Ind-Swift Laboratories gets nod for debt restructuring
Nov8	Ind-Swift Laboratories` director resigns
Oct9	Ind-Swift Laboratories` director resigns
Jul16	Ind Swift Labs bags first order for contract research

MF holdings

No Record Found.

Exchange Information

NSE Indices		BSE Indices
Nifty		Sensex
CNX 100		BSE 100
CNX 200		BSE 200
S&P CNX 500		BSE 500
CNX Midcap		BSE Mid-Cap
CNX Midcap 50		BSE Small-Cap

Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Comparative performance

	1M (%)	3M (%)	6M (%)
Ind-Swift Laboratories Ltd	-10.83	-20.87	-17.99
NIFTY (S&P CNX)	-5.58	-0.37	-1.41
BSE Sensex	-4.95	-0.36	-0.73
BSE 500	-5.78	-1.11	-4.49

F & O Quotes

Futures
Options

Expiry Date

No Record Found.

Key Personnel
Gopal Munjal Director N R Munjal Vice Chairman & M.D. S R Mehta Chairman

Key Address

Registered Office:
Ind-Swift Labs.
SCO 850 Shivalik Enclave,
NAC Manimajra,
Chandigarh,
Chandigarh.
Tel : 91-0172-2730503/2730920
Fax : 91-0172-2730504/2736294

Email : investor:indswiftlabs.com
Website : http://www.indswiftlabs.com

Registrars Details
Alankit Assignments Ltd.
Add. :205/208,
Anarkali Market, Jhandewalan Extn,
New Delhi - 110055.